Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields.

Gorman J, Mason RD, Nettey L, Cavett N, Chuang GY, Peng D, Tsybovsky Y, Verardi R, Nguyen R, Ambrozak D, Biris K, LaBranche CC, Ramesh A, Schramm CA, Zhou J, Bailer RT, Kepler TB, Montefiori DC, Shapiro L, Douek DC, Mascola JR, Roederer M, Kwong PD.

Immunity. 2019 Oct 15;51(4):724-734.e4. doi: 10.1016/j.immuni.2019.09.007. Epub 2019 Oct 2.

PMID:
31586542
2.

Blocking α4β7 integrin binding to SIV does not improve virologic control.

Iwamoto N, Mason RD, Song K, Gorman J, Welles HC, Arthos J, Cicala C, Min S, King HAD, Belli AJ, Reimann KA, Foulds KE, Kwong PD, Lifson JD, Keele BF, Roederer M.

Science. 2019 Sep 6;365(6457):1033-1036. doi: 10.1126/science.aaw7765.

PMID:
31488690
3.

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.

Kong R, Duan H, Sheng Z, Xu K, Acharya P, Chen X, Cheng C, Dingens AS, Gorman J, Sastry M, Shen CH, Zhang B, Zhou T, Chuang GY, Chao CW, Gu Y, Jafari AJ, Louder MK, O'Dell S, Rowshan AP, Viox EG, Wang Y, Choi CW, Corcoran MM, Corrigan AR, Dandey VP, Eng ET, Geng H, Foulds KE, Guo Y, Kwon YD, Lin B, Liu K, Mason RD, Nason MC, Ohr TY, Ou L, Rawi R, Sarfo EK, Schön A, Todd JP, Wang S, Wei H, Wu W; NISC Comparative Sequencing Program, Mullikin JC, Bailer RT, Doria-Rose NA, Karlsson Hedestam GB, Scorpio DG, Overbaugh J, Bloom JD, Carragher B, Potter CS, Shapiro L, Kwong PD, Mascola JR.

Cell. 2019 Jul 25;178(3):567-584.e19. doi: 10.1016/j.cell.2019.06.030.

4.

CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus.

Sutton MS, Ellis-Connell A, Balgeman AJ, Barry G, Weiler AM, Hetzel SJ, Zhou Y, Lau-Kilby AW, Mason RD, Biris KK, Mascola JR, Sullivan NJ, Roederer M, Friedrich TC, O'Connor SL.

J Virol. 2019 Jul 17;93(15). pii: e00537-19. doi: 10.1128/JVI.00537-19. Print 2019 Aug 1.

PMID:
31092584
5.

Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.

Welles HC, Jennewein MF, Mason RD, Narpala S, Wang L, Cheng C, Zhang Y, Todd JP, Lifson JD, Balazs AB, Alter G, McDermott AB, Mascola JR, Roederer M.

PLoS Pathog. 2018 Dec 5;14(12):e1007395. doi: 10.1371/journal.ppat.1007395. eCollection 2018 Dec.

6.

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.

Lertjuthaporn S, Cicala C, Van Ryk D, Liu M, Yolitz J, Wei D, Nawaz F, Doyle A, Horowitch B, Park C, Lu S, Lou Y, Wang S, Pan R, Jiang X, Villinger F, Byrareddy SN, Santangelo PJ, Morris L, Wibmer CK, Biris K, Mason RD, Gorman J, Hiatt J, Martinelli E, Roederer M, Fujikawa D, Gorini G, Franchini G, Arakelyan A, Ansari AA, Pattanapanyasat K, Kong XP, Fauci AS, Arthos J.

PLoS Pathog. 2018 Aug 28;14(8):e1007278. doi: 10.1371/journal.ppat.1007278. eCollection 2018 Aug.

7.

Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures.

Cagigi A, Misasi J, Ploquin A, Stanley DA, Ambrozak D, Tsybovsky Y, Mason RD, Roederer M, Sullivan NJ.

J Infect Dis. 2018 Nov 22;218(suppl_5):S528-S536. doi: 10.1093/infdis/jiy333.

PMID:
30010811
8.

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.

Wang L, Shi W, Chappell JD, Joyce MG, Zhang Y, Kanekiyo M, Becker MM, van Doremalen N, Fischer R, Wang N, Corbett KS, Choe M, Mason RD, Van Galen JG, Zhou T, Saunders KO, Tatti KM, Haynes LM, Kwong PD, Modjarrad K, Kong WP, McLellan JS, Denison MR, Munster VJ, Mascola JR, Graham BS.

J Virol. 2018 Apr 27;92(10). pii: e02002-17. doi: 10.1128/JVI.02002-17. Print 2018 May 15.

9.

Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.

Jegaskanda S, Mason RD, Andrews SF, Wheatley AK, Zhang R, Reynoso GV, Ambrozak DR, Santos CP, Luke CJ, Matsuoka Y, Brenchley JM, Hickman HD, Talaat KR, Permar SR, Liao HX, Yewdell JW, Koup RA, Roederer M, McDermott AB, Subbarao K.

J Virol. 2018 Apr 13;92(9). pii: e01970-17. doi: 10.1128/JVI.01970-17. Print 2018 May 1.

10.

Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.

Mason RD, Welles HC, Adams C, Chakrabarti BK, Gorman J, Zhou T, Nguyen R, O'Dell S, Lusvarghi S, Bewley CA, Li H, Shaw GM, Sheng Z, Shapiro L, Wyatt R, Kwong PD, Mascola JR, Roederer M.

PLoS Pathog. 2016 May 24;12(5):e1005674. doi: 10.1371/journal.ppat.1005674. eCollection 2016 May.

11.

Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.

Mason RD, Welles HC, Adams C, Chakrabarti BK, Gorman J, Zhou T, Nguyen R, O'Dell S, Lusvarghi S, Bewley CA, Li H, Shaw GM, Sheng Z, Shapiro L, Wyatt R, Kwong PD, Mascola JR, Roederer M.

PLoS Pathog. 2016 Apr 11;12(4):e1005537. doi: 10.1371/journal.ppat.1005537. eCollection 2016 Apr. Erratum in: PLoS Pathog. 2016 May;12(5):e1005674.

12.

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

Roederer M, Keele BF, Schmidt SD, Mason RD, Welles HC, Fischer W, Labranche C, Foulds KE, Louder MK, Yang ZY, Todd JP, Buzby AP, Mach LV, Shen L, Seaton KE, Ward BM, Bailer RT, Gottardo R, Gu W, Ferrari G, Alam SM, Denny TN, Montefiori DC, Tomaras GD, Korber BT, Nason MC, Seder RA, Koup RA, Letvin NL, Rao SS, Nabel GJ, Mascola JR.

Nature. 2014 Jan 23;505(7484):502-8. doi: 10.1038/nature12893. Epub 2013 Dec 18.

13.

Evaluation of a rapid HIV testing initiative in an urban, hospital-based dental clinic.

Blackstock OJ, King JR, Mason RD, Lee CC, Mannheimer SB.

AIDS Patient Care STDS. 2010 Dec;24(12):781-5. doi: 10.1089/apc.2010.0159. Epub 2010 Nov 22.

PMID:
21091231
14.

Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutations.

Jones RB, Yue FY, Gu XX, Hunter DV, Mujib S, Gyenes G, Mason RD, Mohamed R, MacDonald KS, Kovacs C, Ostrowski MA.

J Virol. 2009 Sep;83(17):8722-32. doi: 10.1128/JVI.00433-09. Epub 2009 Jun 24.

15.

Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques.

Mason RD, De Rose R, Kent SJ.

Virology. 2009 Jun 5;388(2):315-23. doi: 10.1016/j.virol.2009.03.020. Epub 2009 Apr 24.

16.

Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques.

De Rose R, Mason RD, Loh L, Peut V, Smith MZ, Fernandez CS, Alcantara S, Amarasena T, Reece J, Seddiki N, Kelleher AD, Zaunders J, Kent SJ.

J Med Primatol. 2008 Dec;37 Suppl 2:69-78. doi: 10.1111/j.1600-0684.2008.00329.x.

PMID:
19187433
17.

Protection afforded by live attenuated SIV is associated with rapid killing kinetics of CTLs.

Rollman E, Mason RD, Lin J, Brooks AG, Kent SJ.

J Med Primatol. 2008 Dec;37 Suppl 2:24-32. doi: 10.1111/j.1600-0684.2008.00326.x.

PMID:
19187428
18.

Inactivated simian immunodeficiency virus-pulsed autologous fresh blood cells as an immunotherapy strategy.

Mason RD, Alcantara S, Peut V, Loh L, Lifson JD, De Rose R, Kent SJ.

J Virol. 2009 Feb;83(3):1501-10. doi: 10.1128/JVI.02119-08. Epub 2008 Nov 19.

19.

Low pre-infection levels and loss of central memory CD4+ T cells may predict rapid progression in SIV-infected pigtail macaques.

Mason RD, Rose RD, Seddiki N, Kelleher AD, Kent SJ.

Virology. 2008 Nov 10;381(1):11-5. doi: 10.1016/j.virol.2008.08.042. Epub 2008 Oct 2.

20.

Delivery of immunotherapy with peptide-pulsed blood in macaques.

De Rose R, Fernandez CS, Loh L, Peut V, Mason RD, Alcantara S, Reece J, Kent SJ.

Virology. 2008 Sep 1;378(2):201-4. doi: 10.1016/j.virol.2008.06.006. Epub 2008 Jul 11.

21.

Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood.

De Rose R, Fernandez CS, Smith MZ, Batten CJ, Alcântara S, Peut V, Rollman E, Loh L, Mason RD, Wilson K, Law MG, Handley AJ, Kent SJ.

PLoS Pathog. 2008 May 2;4(5):e1000055. doi: 10.1371/journal.ppat.1000055.

22.

CD4+ T-cell subsets: what really counts in preventing HIV disease?

Mason RD, De Rose R, Kent SJ.

Expert Rev Vaccines. 2008 Mar;7(2):155-8. doi: 10.1586/14760584.7.2.155. Review. No abstract available.

PMID:
18324885
23.

Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques.

Kent SJ, De Rose R, Mokhonov VV, Mokhonova EI, Fernandez CS, Alcantara S, Rollman E, Mason RD, Loh L, Peut V, Reece JC, Wang XJ, Wilson KM, Suhrbier A, Khromykh A.

Virology. 2008 May 10;374(2):528-34. doi: 10.1016/j.virol.2008.01.006. Epub 2008 Feb 12.

25.
26.

Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes.

Mason RD, Bowmer MI, Howley CM, Gallant M, Myers JC, Grant MD.

J Immunol. 2004 Jun 1;172(11):7212-9.

27.

Participating dentists' assessment of the pilot regional online videoconferencing in dentistry (PROVIDENT) project.

Eaton KA, Francis CA, Odell EW, Reynolds PA, Mason RD.

Br Dent J. 2001 Sep 22;191(6):330-5.

28.

A study of videoconferencing for postgraduate continuing education in dentistry in the UK--the teachers' view.

Odell EW, Francis CA, Eaton KA, Reynolds PA, Mason RD.

Eur J Dent Educ. 2001 Aug;5(3):113-9.

PMID:
11520334
29.

Temporary orthosis for the cast-immobilized thumb.

Botte MJ, Mason RD, Gellman H.

J Hand Surg Am. 1993 Jan;18(1):164-5. No abstract available.

PMID:
8423306
30.

The Indian Health Service approach to alcoholism among American Indians and Alaska Natives.

Rhoades ER, Mason RD, Eddy P, Smith EM, Burns TR.

Public Health Rep. 1988 Nov-Dec;103(6):621-7.

31.

Fluorophores as visualization aides in agar growth media.

Lepp CA, Nowlan ED, Mason RD, Ramsey WS.

Experientia. 1979 Jul 15;35(7):868-9.

PMID:
383493
32.

Invertase covalently coupled to porous glass: preparation and characterization.

Mason RD, Weetall HH.

Biotechnol Bioeng. 1972 Jul;14(4):637-45. No abstract available.

PMID:
5036477
33.

Rural health.

Mason RD.

Nebr Med J. 1972 May;57(5):184-6. No abstract available.

PMID:
5026928
34.

Malpractice insurance.

Mason RD.

Nebr Med J. 1971 Dec;56(12):467-9. No abstract available.

PMID:
5130344
35.

Medical education.

Mason RD.

Nebr State Med J. 1971 Jul;56(7):288-9. No abstract available.

PMID:
4254095

Supplemental Content

Loading ...
Support Center